About Us

About our research director: Dr Shelley Hyman
BSc (Psychol), MClinNeuropsych, PhD (Med) MAPS CCN

Dr Shelley Hyman is the research director of NeuroResources. She has an undergraduate psychology degree with honours from the University of NSW, a Masters in Clinical Neuropsychology from Macquarie University, and a PhD from Sydney University specialising in paediatrics. Following her PhD she received a 2 year award from the Children's Tumour Foundation (New York) for her postdoctoral research. She worked for 8 years at the Children's Hospital at Westmead as a psychologist running a learning disabilities clinic for children with genetic disorders (NF1). She has also worked overseas for 2 years  as a consultant at both the Schneider Children's Medical Center of Israel and the Dana Children's Hospital. She has had experience with a variety of neurodevelopmental/ genetic disorders, head injury, brain tumours, epilepsy, pervasive developmental disorders (autism), ADHD and learning disabilities.

Dr Hyman is a fully registered psychologist under the NSW Psychologist Registration Board. She is also a full member of the Australian Psychological Society and the International Neuropsychological Society. She is a member of the College of Clinical Neuropsychologists. She has raised numerous grants and awards for her internationally recognised research, totalling over $2 million. In 2005 she was awarded a large 3 year grant from the US army to conduct international research into cognitive remediation programs with children. She currently runs a specialist clinic in Bondi Junction Sydney- The Sydney Cognitive Development Centre

Publications

Hyman, SL., Gill, D., Shores E.A., Steinberg, A., & North, K.N. (2007) Specific Regions of T2-Hyperintensities in Children with NF1 and their relationship to Cognitive Functioning. Journal of Neurology, Neurosurgery & Psychiatry, 78, 1088-1091.

Hyman, S.L., Shores, E.A., Gill, D., & North, K.N. (2006). Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit-hyperactivity disorder. Developmental Medicine & Child Neurology, 48, 973-977.

Gill, D., Hyman, SL., Steinberg, A & North, K.N. (2006). Age-related findings on MRI in Neurofibromatosis type 1.  Pediatric Radiology; 36: 1048-1056.

Hyman, SL., Shores E.A., & North, K.N. (2005). The Nature and Frequency of Cognitive Deficits in Children with Neurofibromatosis Type 1. Neurology, 65, 1037-1044.

Hyman, SL., Shores E.A., Gill, D., Steinberg, A., & North, K.N. (2004). Children with Neurofibromatosis Type 1: Neuropsychological and Neuroradiological Aspects. Journal of the International Neuropsychological Society, 10, 40.

Hyman, SL. Neurofibromatosis Type 1: Cognitive Profile, Natural History and Pathogenesis.  2004. PhD Dissertation.

Hyman, S.L., Shores E.A., Gill, D., Steinberg, A.,  & North, K.N. (2003). Natural History of Neuropsychological Ability and T2-Hyperintensities in Patients with Neurofibromatosis Type 1. Neurology, 60, 1139-1145.

North, K.N, Hyman, S., & Barton, B. (2002). Cognitive Functioning in Neurofibromatosis Type 1. Journal of Child Neurology, 17:616-623.

Young, H., Hyman, S. & North, K. (2002) Neurofibromatosis Type 1: Clinical Manifestations and Exceptions to the rule. Journal of Child Neurology, 17:624-632

Hyman, S., North, A., Shores, A., Gill, D., & Steinberg, A. (2002). Natural history of cognitive deficits and brain lesions in neurofibromatosis 1. Journal of International Neuropsychological Society, 8, 499.

Hyman, S.L., Shores E.A., Steinberg, A., Gill, D., & North, K.N. (2002). Natural History of Neuropsychological Ability and T2-Hyperintensities in Patients with Neurofibromatosis Type 1. Brain Impairment, 3, 80.

Hyman, S.L. An analysis of the mechanisms underlying the phenomenon of memory reactivation. 1997. Honours Thesis.